Search

The inaugural Vilcek Prize in Biomedical Research has been awarded by The Vilcek Foundation to Joan Massagué, Chairman of the Sloan Kettering Institute's Cancer Biology and Genetics Program.

… Saturday, April 1, 2006 Summary The inaugural Vilcek Prize in Biomedical Research has been awarded by The Vilcek Foundation to Joan Massagué, Chairman of the Sloan Kettering Institute’s Cancer Biology and Genetics Program. The inaugural Vilcek Prize in Biomedical Research has been awarded by The Vilcek

Learn how nurses stay resilient by dealing effectively with stress on the job.

… Thursday, December 14, 2017 Summary Nursing can be stressful and emotionally exhausting, leading to risk of compassion fatigue. But there are many effective methods available for reducing stress and managing grief that may arise. Many nurses find their work to be tremendously fulfilling. But nursing

MSK researchers shed new light on G-quadruplexes, a type of secondary DNA structure that has attracted attention as a potential therapeutic target in cancer.

… Friday, March 7, 2025 Every day, billions of cells in your body divide, helping to replace old and injured cells with new ones. And each time this happens, your entire genetic library — your genome, which totals more than 3 billion base pairs of DNA — has to be copied, precisely, from the parent cell

Advances in our understanding of the biology of breast cancer are guiding the development of individualized treatment plans. We outline the clinical case history of young breast cancer patient, Elizabeth Shelley, including our rational for not proceeding with the originally prescribed chemotherapy.

… Friday, November 10, 2017 Advances in our understanding of the biology of breast cancer are guiding the development of individualized treatment plans, aiming to provide each patient with the best chance for a cure while optimizing their quality of life. The ideal approach can mean less treatment in some

Research confirms a sound strategy for designing a therapeutic vaccine for pancreatic cancer.

… Thursday, May 19, 2022 Pancreatic cancer Pancreatic cancer is known for its grim prognosis. But remarkably, a very small group of patients manage to beat the odds and survive. In the past few years, researchers at Memorial Sloan Kettering Cancer Center (MSK), led by physician-scientist Vinod Balachandran

A team of experts at Memorial Sloan Kettering shared their insights on gynecologic cancer and women’s health in an Information Session for patients, caregivers and those at increased risk for the diseases.

… Wednesday, September 30, 2020 A team of experts at Memorial Sloan Kettering shared their insights on gynecologic cancer and women’s health in an Information Session for patients, caregivers and those at increased risk for the diseases.   Members of the MSK community joined the session to have their most

Learn about different medications cancer patients can take to cope with depression and anxiety.

… Thursday, October 20, 2016 Summary Medication isn’t for everyone, but it can help those in significant distress. Memorial Sloan Kettering psychiatrist Jeffrey Freedman shares the many ways he and other members of MSK’s Counseling Center help people cope with their cancer. Highlights For some people,

Results from a clinical trial and animal studies provide support for targeting the HER2 protein in multiple cancer types.

… Wednesday, March 25, 2020 The HER2 study team (from left to right): Bob Li, Hai-Yan Tu, Mackenzie Myers, Flavia Michelini, Emiliano Cocco, Sandra Misale, and Maurizio Scaltriti The HER2 study team (from left): Bob Li, Hai-Yan Tu, Mackenzie Myers, Flavia Michelini, Emiliano Cocco, Sandra Misale, and Maurizio

The FDA has approved nirogacestat (OgsiveoTM), a targeted therapy for desmoid tumors. A recent phase 3 clinical trial found that the drug significantly shrank desmoid tumors in 41% of patients. Desmoid tumors (also known as aggressive fibromatosis) are a rare type of soft tissue tumor.

… Tuesday, November 28, 2023 Update: On November 27, 2023, the U.S. Food and Drug Administration approved nirogacestat (Ogsiveo™) for adults with desmoid tumors that cannot be treated with surgery alone. The approval was based on research led by investigators at Memorial Sloan Kettering Cancer Center.

Women on Long Island who don’t have insurance or who are underinsured may be able to take advantage of free mammograms at Memorial Sloan Kettering Cancer Center Commack.

… Tuesday, May 8, 2012 Women on Long Island who don’t have insurance or who are underinsured may be able to take advantage of free mammograms at Memorial Sloan Kettering Cancer Center Commack . The Center has contracted with the New York State Cancer Services Program (CSP) of Western Suffolk County to